Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Neuropathol Exp Neurol. 2013 Jul;72(7):708–715. doi: 10.1097/NEN.0b013e31829a25b9

Figure 4.

Figure 4

Percentage of cases without cerebral amyloid angiopathy (CAA) by APOE genotype. The frequency of cases showing a lack of observed CAA pathology (CAA score of 0) in the meninges and parenchyma of the frontal, occipital, parietal, and temporal lobes for individuals with each of the more common APOE genotypes (ε2/3, ε3/3, ε3/4, and ε4/4).

HHS Vulnerability Disclosure